Adamas Pharmaceuticals Stock Price

0.36 (7.63%)
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamas Pharmaceuticals Inc ADMS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.36 7.63% 5.08 16:00:10
Open Price Low Price High Price Close Price Prev Close
5.00 4.81 5.25 5.08 4.72
Bid Price Ask Price Spread News
5.00 5.12 0.12 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,292 700,040 $ 4.98 $ 3,487,855 171,722 1.90 - 6.15
Last Trade Time Type Quantity Stock Price Currency
16:00:06 formt 947 $ 5.08 USD

Adamas Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 144.88M 28.52M 23.75M $ 54.64M $ -40.00M -3.80 -2.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Adamas Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.495.254.384.60135,3870.5913.14%
1 Month4.625.254.114.57143,2820.469.96%
3 Months3.095.403.054.45168,5351.9964.4%
6 Months2.605.552.43014.43327,0512.4895.38%
1 Year5.136.151.903.81348,578-0.05-0.97%
3 Years40.7141.741.9012.72524,436-35.63-87.52%
5 Years21.6544.001.9015.99479,490-16.57-76.54%

Adamas Pharmaceuticals Description

Adamas Pharmaceuticals Inc discovers, develops, and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease. It operates in one reportable segment: the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company generates its revenues primarily from the United States.

Your Recent History
Adamas Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.